Karyopharm Therapeutics Inc. (KPTI) Operating income 2016–2025
Karyopharm Therapeutics Inc. (KPTI) annual operating income history from SEC filings — each fiscal year as reported.
-$90.7MFY2025 · since FY2016: -$110.7M → -$90.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$90.7M | +24.1% |
| FY2024 | -$119.4M | +7.8% |
| FY2023 | -$129.5M | +8.9% |
| FY2022 | -$142.2M | -44.7% |
| FY2021 | -$98.3M | +42.8% |
| FY2020 | -$171.8M | +9.2% |
| FY2019 | -$189.3M | -5.2% |
| FY2018 | -$179.9M | -37.8% |
| FY2017 | -$130.5M | -17.9% |
| FY2016 | -$110.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice